1.A study for mass screening of galactosemia using galactitol level by spot urine method among Korean infants.
Jin Tae KIM ; Chong Won BAE ; Sa Jun CHUNG ; Chang Il AHN
Journal of the Korean Pediatric Society 1991;34(7):949-958
No abstract available.
Galactitol*
;
Galactosemias*
;
Humans
;
Infant*
;
Mass Screening*
2.Surfactant Therapy for Neonatal Respiratory Distress Syndrome: A Review of Korean Experiences over 17 Years.
Journal of Korean Medical Science 2009;24(6):1110-1118
We undertook a multi-hospital collective study to evaluate outcomes of neonatal respiratory distress syndrome (RDS) patients treated with pulmonary surfactant (PS) over 17 yr in Korea (Group I; 1990/91, Group II; 1996, Group III; 2002, and Group IV; 2007). There were 60 neonates in Group I (16 hospitals), 1,179 in Group II (64), 1,595 in Group III (62), and 1,921 in Group IV (57). We adopted Bomsel's classification to evaluate initial chest radiographic findings, categorized RDS severities, and classified response types to PS therapy. Almost all cases were treated using a single dose in Groups I and II, but 19.5% received multiple-dose therapy in Group IV. In Group IV, Bomsel's stages III and IV composed 62.9% and initial severities of mild, moderate, and severe RDS were 23.0%, 42.0%, and 35.0%. More infants showed good response in Groups II, III, and IV than in Group I (71.7%, 66.8%, and 69.2% vs. 58.3%). Complications and mortality rate were lower in Group IV than in Groups I, II, and III (mortality rate: 14.3% vs. 40.0%, 30.0%, and 18.7%). We conclude that PS therapy in neonates with RDS had a remarkable impact on improving clinical course and outcomes over 17 yr in Korea.
Birth Weight
;
Female
;
Gestational Age
;
Humans
;
Infant, Newborn
;
Infant, Premature, Diseases/epidemiology/mortality/pathology/*therapy
;
Korea/epidemiology
;
Longitudinal Studies
;
Pregnancy
;
Pulmonary Surfactants/*therapeutic use
;
Questionnaires
;
Radiography, Thoracic
;
Respiratory Distress Syndrome, Newborn/epidemiology/mortality/pathology/*therapy
;
Treatment Outcome
4.Reconstruction of the lower leg with the reverse-pedicled anterior tibial flap: a case report.
Won Suk OH ; Yong Bae KIM ; Young Man LEE ; Soon Jae YANG ; Chong Sup PARK
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1993;20(5):1100-1105
No abstract available.
Leg*
5.Osteolysis around Screw in Cementless Total Knee Replacement.
Dae Kyung BAE ; Shun Wook CHUNG ; Chong Won LEE ; Hyoung Seop YANG
The Journal of the Korean Orthopaedic Association 1998;33(5):1301-1306
Screw fixation of the tibial component offers advantages in initial fixation in cementless total knee replacement. But the high incidence of screw related osteolysis was reported. The purpose of this study is to evaluate clinical results of cementless total knee replacement and to look for radiographic changes at the screw-bone interface. From January 1988 to December 1991, primary cementless total knee replacements with Miller Galante I (Zimmer, Warsaw. IN) were performed to 53 knees at Kyung Hee university hospital. Among them, 21 cases which could be followed-up for more than 4 years were studied retrospectively about the clinical and radiographic results. The mean follow-up period was 5.5 years(ranged from 4.2 years to 8 years). At the last follow-up period, knee scores of Hospital for Special Surgery were improved from mean 56 points to 90 points and the range of motion from 72 degrees to 110 degrees. In the last follow-up radiographs, osteolysis around screw was classified as linear(type I ), cystic(type II ) and cavitary(type III ) according to the width of the lucency around screws. Among 21 cases, radiographic findings of osteolysis around screw were detected in 10 cases but not in 11 cases. But clinical results were similar between these two groups. Among the total 84 screws(4 screws in each case), 21 screws(25%) showed screw related osteolysis typed as I in 13 screws(15.4%), II in 4 screws(4.8%) and III in 4 screws(4.8%). Among the 13 cases that followed-up more than 6 years, 20 screws(38%) showed screw related osteolysis typed as in 11 screws(21.2%), I in 5 screws(9.6%) and II in 4 screws(7.8%). The most frequently involved site of screw was anteromedial(33.3%). In conclusion, after mean 5.5 year follow-up, the clinical results were satisfactory but the development of osteolysis around screw might be an indicator of the implant failure.
Arthroplasty, Replacement, Knee*
;
Follow-Up Studies
;
Incidence
;
Knee
;
Osteolysis*
;
Range of Motion, Articular
;
Retrospective Studies
6.Effects of Wild - type p53 Gene Transfection into Human Colon Cancer Cell Line.
Hyun Ok KIM ; Woo Ho KIM ; Soo In BAE ; He Won LEE ; Chong Jai KIM ; Sung Youl HONG ; Yong Il KIM
Journal of the Korean Cancer Association 1999;31(2):367-376
PURPOSE: In colon cancer, the most frequent genetic alteration is found in p53 tumor suppressor gene residing on the short arm of chromosome 17. In order to investigate the significance of wild-type p53, we transfected wild type p53 into human colon cancer cell lines and analysed tbeir biologic effects. MATERIALS AND METHODS: For analysis of p53 status in cell lines, polymerase chain reaction-single stranded confonnation polymorphism (PCR-SSCP), PCR-direct sequencing and Western blot analysis were employed. Transient transfection with liposome-p53 complex was followed by cell biologic assay. RESULTS: We found that twelve of fifteen human colon cancer cell lines showed mutation of p53 by PCR-SSCP method. These results almost corresponded to p53 protein accumulations assessed by Westem blot using PAbl801. After transfection with lipafect- AMINE and wild type p53 complex on p53 mutant type cell line (LS1034), viability was reduced to 17.9%, and invasiveness was reduced to 37.3%. Morphologically, wild type p53 transfected cells showed lumen formation and apoptosis after induction of differentiation by Matrigel. CONCLUSION: Wild type p53 transfection into p53 mutated colon cancer ceil line resulted in restoration of tumor suppressor effect of p53, and this model would be one of the experimental systems for p53-based gene therapy.
Apoptosis
;
Arm
;
Biological Assay
;
Blotting, Western
;
Cell Line*
;
Chromosomes, Human, Pair 17
;
Colon*
;
Colonic Neoplasms*
;
Genes, p53*
;
Genes, Tumor Suppressor
;
Genetic Therapy
;
Humans*
;
Liposomes
;
Transfection*
7.Changes in Survival Rate for Very-Low-Birth-Weight Infants in Korea: Comparison with Other Countries.
Jae Won SHIM ; Hyun Seung JIN ; Chong Woo BAE
Journal of Korean Medical Science 2015;30(Suppl 1):S25-S34
Recently the Korean Neonatal Network (KNN) was established in order to enhance treatment outcomes further through the registration of very-low-birth-weight infants (VLBWI) data. The present study was conducted on 2,606 VLBWI, 2,386 registered and 220 un-registered, in the KNN participating centers, with the objective of reporting on recent survival rates of VLBWI in Korea and verifying the changing trends in survival rates with data from the 1960s and beyond. The study also aimed to compare the premature infants' survival rate in Korea with those reported in neonatal networks of other countries. The recent survival rate of VLBWI increased more than twice from 35.6% in the 1960s to 84.8%, and the survival rate of the extremely low birth weight infants (ELBWI) increased by more than 10 times, indicating improvement of the survival rate in premature infants with lower birth weight and gestational age. Comparison of VLBWI between countries showed improved survival rates according to each birth weight group in Canada, Australia-New Zealand, and European countries with Japan at the head, but in terms of comparison based on gestational age, differences, except for Japan, have been reduced. Efforts to increase the survival rate of premature infants in Korea with low birth rate are inevitable, and they should be the foundation of academic and clinical development based on its network with advanced countries.
Databases, Factual
;
Europe
;
Gestational Age
;
Humans
;
Infant
;
Infant Mortality/*trends
;
Infant, Extremely Low Birth Weight
;
Infant, Newborn
;
Infant, Premature
;
*Infant, Very Low Birth Weight
;
Japan
;
Republic of Korea
8.Birth Statistics and Mortality Rates for Neonatal Intensive Care Units in Korea during 2007: Collective Results from 57 Hospitals.
Won Ho HAHN ; Ji Young CHANG ; Chong Woo BAE
Journal of the Korean Society of Neonatology 2009;16(1):36-47
PURPOSE:To evaluate the neonatal statistics on a national basis, data for birth characteristics and neonatal mortality were collected and analyzed from 57 hospitals in Korea. METHODS:Questionnaires were distributed to determine the characteristics of neonatal births and mortality rates in 57 hospitals in Korea during 2007. We analyzed the characteristics of all inborn births and hospitalized neonates in the neonatal care units (NICUs) and compared the results with published Korean data from 1996 and 2002. RESULTS:A total of 40,433 inborn live births were reported from the 57 hospitals during 2007. Pre-term, term, and post-term births comprised 24.2%, 75.6%, and 0.2% of the neonates, respectively. Low birth weight infants (LBWIs), very low birth weight infants (VLBWIs), and extremely low birth weight infants (ELBWIs) made up 22.0%, 4.6%, and 1.7% of the neonates, respectively. A total of 21,957 (collected by gestational period) and 21,356 (collected by birth weight) neonates were hospitalized in the 57 NICUs. Pre-term, term, and post-term neonates comprised 39.8%, 59.8%, and 0.4% of the neonates, respectively. LBWIs, VLBWIs, and ELBWIs made up 37.3%, 9.5%, and 3.3% of the neonates, respectively. Pre-term, term, and post-term neonates had mortality rates of 4.5%, 0.7%, and 3.7%, respectively, while the mortality rates of LBWIs, VLBWIs, and ELBWIs were 4.7%, 15.3%, and 32.2%, respectively. In comparison with prematurity data from 1996 and 2002, LBWIs, and ELBWIs had a marked increase in birth frequency and a decreased mortality rate in Korea during 2007. CONCLUSION:The number of live births and the survival rate of pre-term neonates, especially VLBWIs and ELBWIs, are increasing. Even though the outcomes of neonatal care are improving, further efforts to manage these premature infants are needed.
Birth Rate
;
Humans
;
Infant
;
Infant Mortality
;
Infant, Low Birth Weight
;
Infant, Newborn
;
Infant, Premature
;
Infant, Very Low Birth Weight
;
Intensive Care Units, Neonatal
;
Intensive Care, Neonatal
;
Korea
;
Live Birth
;
Parturition
;
Survival Rate
9.Decreased Expression of Surfactant Protein Genes Is Associated with an Increased Expression of Forkhead Box M1 Gene in the Fetal Lung Tissues of Premature Rabbits.
Won Ho HAHN ; Ji Young CHANG ; Kyung Suk LEE ; Chong Woo BAE
Yonsei Medical Journal 2013;54(6):1422-1429
PURPOSE: Recently, Forkhead box M1 (FoxM1) was reported to be correlated with lung maturation and expression of surfactant proteins (SPs) in mice models. However, no study has been conducted in rabbit lungs despite their high homology with human lungs. Thus, we attempted to investigate serial changes in the expressions of FoxM1 and SP-A/B throughout lung maturation in rabbit fetuses. MATERIALS AND METHODS: Pregnant New Zealand White rabbits were grouped according to gestational age from 5 days before to 2 days after the day of expected full term delivery (F5, F4, F3, F2, F1, F0, P1, and P2). A total of 64 fetuses were enrolled after Cesarean sections. The expressions of mRNA and proteins of FoxM1 and SP-A/B in fetal lung tissue were tested by quantitative reverse-transcriptase real-time PCR and Western blot. Furthermore, their correlations were analyzed. RESULTS: The mRNA expression of SP-A/B showed an increasing tendency positively correlated with gestational age, while the expression of FoxM1 mRNA and protein decreased from F5 to F0. A significant negative correlation was found between the expression levels of FoxM1 and SP-A/B (SP-A: R=-0.517, p=0.001; SP-B: R=-0.615, p<0.001). CONCLUSION: Preterm rabbits demonstrated high expression of FoxM1 mRNA and protein in the lungs compared to full term rabbits. Also, the expression of SP-A/B was inversely related with serial changes in FoxM1 expression. This is the first report to suggest an association between FoxM1 and expression of SP-A/B and lung maturation in preterm rabbits.
Animals
;
Blotting, Western
;
Female
;
Fetus/*metabolism
;
Forkhead Transcription Factors/*metabolism
;
Lung/*metabolism
;
Pregnancy
;
Pulmonary Surfactant-Associated Protein A/genetics/*metabolism
;
Rabbits
10.In Vitro Activities of Cefatrizine/clavulanic Acid Against Major Clinical Isolates of Bacteria.
Jae Lim CHUNG ; Young Ah KIM ; Hee Bong SHIN ; Jeong Won SHIN ; Kyung Won LEE ; Yun Sop CHONG ; Jang Hyeon PARK ; Won Bae KIM
Korean Journal of Clinical Microbiology 1999;2(2):182-193
BACKGROUND: beta-lactam antibiotics are one of the most frequently used antimicrobial agents. However, with the increase of beta-lactamase-producing bacteria, penicillins arid 1 st generation cephalosporins have become less useful. Cefatrizine and clavulanic acid combination (CTCA) was developed to restore the activity. The aim of this study was to determine the activities of CTCA against major recent clinical isolates. METHODS: Aerobic and anaerobic bacteria tested were isolated from clinical specimens in Severance Hospital during 1996 to 1999. Antimicrobial susceptibility was determined by the NCCLS agar dilution methods. RESULTS: MICs of cefatrizine (CT) and CTCA were similar for methicillin-susceptible Staphylococcus aureus, Streptococcus pyogenes and S. pneumoniae. For Moraxella (Branhamella) catarrhalis, MIC90 CTCA was 1 microgram/mL, which was 1/8-fold lower than that of cefatrizine. MIC90S of CTCA for Escherichia coli and Klebsiella pneumoniae were 4 microgram/mL and 8 microgram/mL, respectively, which were 1/4- to 1/16-fold lower than those of CT. However, it was less active against Citrobacter freundii, Enterobacter cloacae and Serratia marcescens. Against Bacteroides fragilis group organisms, it showed good activities similar to those of other beta-lactam and beta-lactamase inhibitor combinations. CONCLUSIONS: CTCA showed good antimicrobial activities against M. (B.) catarrhalis, Haemophilus influenzae, Neisseria gonorrhoeae, extended spectrum beta-lactamase-producing E. coli and K. pneumoniae, Proteus vulgaris and B. fragilis. In conclusion, it would be useful for the treatment of infections due to those organisms, and for the empirical treatment of respiratory and urinary tract infections.
Agar
;
Anti-Bacterial Agents
;
Anti-Infective Agents
;
Bacteria*
;
Bacteria, Anaerobic
;
Bacteroides fragilis
;
beta-Lactamases
;
Cefatrizine
;
Cephalosporins
;
Citrobacter freundii
;
Clavulanic Acid
;
Enterobacter cloacae
;
Escherichia coli
;
Haemophilus influenzae
;
Klebsiella pneumoniae
;
Moraxella (Branhamella) catarrhalis
;
Neisseria gonorrhoeae
;
Penicillins
;
Pneumonia
;
Proteus vulgaris
;
Serratia marcescens
;
Staphylococcus aureus
;
Streptococcus pyogenes
;
Urinary Tract Infections